- Home
- SKWD vs MLTX Comparison
SKWD vs MLTX Comparison
Compare SKWD & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKWD
- MLTX
- Stock Information
- Founded
- SKWD 2007
- MLTX 2021
- Country
- SKWD United States
- MLTX Switzerland
- Employees
- SKWD N/A
- MLTX N/A
- Industry
- SKWD Property-Casualty Insurers
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- SKWD Finance
- MLTX Health Care
- Exchange
- SKWD Nasdaq
- MLTX Nasdaq
- Market Cap
- SKWD 2.1B
- MLTX 2.3B
- IPO Year
- SKWD 2023
- MLTX N/A
- Fundamental
- Price
- SKWD $59.87
- MLTX $38.60
- Analyst Decision
- SKWD Buy
- MLTX Strong Buy
- Analyst Count
- SKWD 12
- MLTX 8
- Target Price
- SKWD $63.25
- MLTX $80.50
- AVG Volume (30 Days)
- SKWD 384.3K
- MLTX 423.9K
- Earning Date
- SKWD 05-01-2025
- MLTX 05-20-2025
- Dividend Yield
- SKWD N/A
- MLTX N/A
- EPS Growth
- SKWD 9.29
- MLTX N/A
- EPS
- SKWD 2.98
- MLTX N/A
- Revenue
- SKWD $1,213,759,000.00
- MLTX N/A
- Revenue This Year
- SKWD $16.85
- MLTX $103.42
- Revenue Next Year
- SKWD $12.65
- MLTX N/A
- P/E Ratio
- SKWD $19.98
- MLTX N/A
- Revenue Growth
- SKWD 26.30
- MLTX N/A
- 52 Week Low
- SKWD $33.42
- MLTX $31.42
- 52 Week High
- SKWD $60.40
- MLTX $58.26
- Technical
- Relative Strength Index (RSI)
- SKWD 67.42
- MLTX 53.31
- Support Level
- SKWD $57.85
- MLTX $36.75
- Resistance Level
- SKWD $60.22
- MLTX $42.90
- Average True Range (ATR)
- SKWD 2.03
- MLTX 2.06
- MACD
- SKWD 0.54
- MLTX 0.03
- Stochastic Oscillator
- SKWD 94.45
- MLTX 58.04
About SKWD Skyward Specialty Insurance Group Inc.
Skyward Specialty Insurance Group Inc is a specialty insurance company that delivers commercial property and casualty products and solutions on a non-admitted and admitted basis. The firm has one reportable segment through which it offers a broad array of insurance coverages to several market niches. It operates multiple lines of business, including general liability, excess liability, professional liability, commercial auto, group accident, health, property, surety, and workers' compensation.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.